logo-large
  • Browse Categories

Publications by authors named "Roy Lysaa"

Claim this Profile
I
Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux.
Anna Subbotina, Aina W Ravna, Roy A Lysaa, Ruben Abagyan, Ryszard Bugno

J Pharm Pharmacol· June 2017


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors.
Lena Aronsen, Elin Orvoll, Roy Lysaa, Aina W Ravna, Georg Sager

Eur J Pharmacol· December 2014


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel cGMP efflux inhibitors identified by virtual ligand screening (VLS) and confirmed by experimental studies.
Georg Sager, Elin Ø Ørvoll, Roy A Lysaa, Irina Kufareva, Ruben Abagyan

J Med Chem· April 2012


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New techniques for optimization of thiopurine therapy in leukemia and transplantation].
Thrina Loennechen, Roy Andre Lysaa, Trude Giverhaug, Ingebrigt Sylte, Lars-Eirik Mathiesen

Tidsskr Nor Laegeforen· April 2002


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: